Crohn's disease, which affects more than 300,000 adults in the United States, can be typically treated with corticosteroids or antitumor necrosis factor-α (anti-TNF) drugs. Expanding the use of anti-TNF drugs to all eligible patients can lead to better patient outcomes.
One in three adults in the United States are at risk for diabetes. Identifying which patients would benefit most from treatment may help patients and clinicians, such as doctors or nurses, prevent diabetes among patients at greatest risk.
Many patients with psoriasis experience difficulty in accessing dermatologists for care, but recent innovations in telemedicine have created new opportunities for them to access dermatological care.
For children with acute upper respiratory tract infections, narrow-spectrum antibiotics worked just as well as broad-spectrum antibiotics at killing the bacteria within three days.
Less intensive follow-up testing after surgery for colorectal cancer can reduce the burden on patients, their families, and employers with no significant effect on health outcomes.
Reducing daily blood sugar testing for people with type 2 diabetes who are not on insulin does not affect patients’ health and provides significant savings in healthcare costs.
Parents and caregivers can avoid losing thousands of hours of work time per year nationally if children with serious infections receive oral instead of IV antibiotics after they leave the hospital.
Using a simple decision aid can help many patients with chest pain safely avoid unnecessary hospitalizations for follow-up testing. That can mean significant savings.
For stroke survivors who have atrial fibrillation, treatment with a blood thinner after leaving the hospital can prevent recurrent strokes and give patients more time at home.
The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.
